It is known that in vitro cells with G6PD knockdown are more susceptible to viral infections [42], and during the recent COVID-19 pandemic, G6PD deficiency was seen as an aggravating factor in the clinical picture and prognosis [37]. Here, G6PD is linked to viral infectious disease.